U.S. health officials on Thursday said they will spend $350 million in four states to study ways to best deal with the nation's opioid crisis on the local level, with a goal of reducing opioid-related overdose deaths by 40 percent over three years in selected communities in those states.
April 17 Abbott Laboratories Inc
reported higher-than-expected quarterly profit and sales on
surging demand for its glucose monitoring device, but an
unchanged forecast along with regulatory uncertainty kept
investors on the edge.
Johnson & Johnson on Tuesday reported a first-quarter profit that exceeded Wall Street expectations on higher sales of its prescription medicines, including a double-digit increase for its psoriasis treatment Stelara, even as the company faces fierce competition for some of its other important drugs.
Two leading shareholder advisory firms threw their support behind Allergan Plc's management by recommending that investors vote against billionaire investor David Tepper's proposal that the Botox maker immediately split the roles of chief executive officer and chairman.
The U.S. Food and Drug Administration on Monday refused to fully review the marketing application for Zogenix Inc's treatment for seizures associated with Dravet syndrome, a rare form of childhood epilepsy.
(Reuters Health) - The most common triggers of atrial fibrillation - an irregular heart rhythm that's a leading cause of stroke - are avoidable behaviors like drinking alcohol or coffee, a recent study suggests.
The Apple Watch was able to detect irregular heart pulse rates that could signal the need for further monitoring for a serious heart rhythm problem, according to data from a large study funded by Apple Inc, demonstrating a potential future role for wearable consumer technology in healthcare. | Video
The U.S. Food and Drug Administration (FDA) on Wednesday released formal plans to curb the sale of flavored e-cigarettes and slow a surge in teenage use of the popular nicotine devices.